News

Health Cuts Would Result in Fewer Drugs for Americans, Budget Office Reports
The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising ...
Medscape6h
From Lab to Landmark Therapy: Meet the Woman Behind GLP-1
Biochemist Svetlana Mojsov, honored for GLP-1 research that has transformed metabolic disease care, says she’s grateful to ...
Commentary: What we get wrong about prescriptions, chronic disease
Drug development is a decade-long, costly process replete with failures. If we don’t incentivize investments in research and ...
GSK's blood cancer drug fails to secure US FDA advisers' support
The U.S. FDA's panel of independent advisers on Thursday recommended against GSK's blood cancer drug Blenrep, citing concerns ...
Fierce Pharma4h
Fierce Pharma Asia—China biotech deal boom; Takeda's narcolepsy win; Sino Biopharm's LaNova buyout
Biotech deals involving assets developed in China are surging, a Jefferies report shows. | Biotech deals involving assets ...
Harvard Kennedy School4h
New research shows that powerhouse institutions play an outsized role in scientific innovation and discovery
Where does scientific discovery happen, and why does it matter? A recent analysis by Amitabh Chandra, Harvard Kennedy School professor of Public Policy, and Connie Xu, a Harvard PhD candidate in ...
Science Daily17h
ScienceDaily: Your source for the latest research news
Breaking science news and articles on global warming, extrasolar planets, stem cells, bird flu, autism, nanotechnology, dinosaurs, evolution -- the latest discoveries ...